Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02427451
Brief Title: Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia

First Submitted : March 4, 2015
First Submitted that Met QC Criteria : April 24, 2015
First Posted : April 28, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : May 20, 2019
Last Update Posted : May 22, 2019